Why Veru Stock Is Soaring

Veru Inc VERU shares are trading higher Wednesday after the company announced the publication of the results from a Phase 3 COVID-19 study evaluating the efficacy and safety of oral sabizabulin for the treatment of hospitalized moderate-severe COVID-19 patients at high risk for acute respiratory distress syndrome and death.

Sabizabulin is a novel dual antiviral and anti-inflammatory agent. The Phase 3 trial evaluated once-a-day dosing of sabizabulin versus placebo in approximately 210 hospitalized COVID-19 patients.

Veru said Sabizabulin treatment resulted in a clinically and statistically meaningful 55.2% relative reduction in deaths in the intent to treat population. Sabizabulin also had a significant and clinically meaningful reduction in days in ICU, days on mechanical ventilation and days in the hospital. 

Veru is a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases, as well as for the management of breast and prostate cancers.

See Also: Why Exxon Mobil Shares Are Diving Again Today

VERU Price Action: Veru has a 52-week high of $17.50 and a 52-week low of $4.34.

The stock was up 13.6% at $13.09 at press time, according to data from Benzinga Pro.

Photo: fernando zhiminaicela from Pixabay.

Posted In: why it's movingSmall CapMoversTrading Ideas

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.